MENU
ALNY
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Alnylam Pharmaceuticals (ALNY) Ownership - Who owns Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
675 West Kendall Street
Phone
+1 617 551-8200
Employees
2100
Web
https://www.alnylam.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
34.53B
P/E Ratio
N/A
Total Cash
2.69B
Projected Growth
N/A
Total Debt
1.3B
Revenue
2.25B
Risk (Beta)
0.40
Dividend Yield
N/A
Total Cash/Share
20.82
Total Debt/Equity
N/A
Revenue/Share
17.61 USD as % of share price
Fundamentals
ALNY
Capitalization
34.5B
P/E Ratio
N/A
Risk (Beta)
0.40
Dividend Yield
N/A
Total Cash
2.7B
Total Cash/Share
20.82
Total Debt
1.3B
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
17.61%
Revenue
2.25B
ROE
N/A
Book Value
67.1M
P/B Ratio
500.00
Cash Flow
N/A
Earnings
-2.18
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.29M
Current Ratio
2.78
Current Revenue Per Employee
265993.72
Dividends Per Share - Security
N/A
EBITDA
-178.85M
Float
N/A
Float - Current
N/A
Gross Income Margin
82.67
Revenue To Assets
-6.89
Shares Held By Institutions
73.4B
Shares Outstanding - Current
129M
Total Liabilities
4.17B
Total Volume MTD
N/A
Value
-1
Gain YTD
13.395
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of therapeutics based on RNA interference
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
675 West Kendall Street
Phone
+1 617 551-8200
Employees
2100
Web
https://www.alnylam.com